News from the BioRegion STERN

Here you'll find all press releases and news from companies and institutes in the STERN BioRegion.

04/04/2018 | Curetis GmbH

Curetis’ Unyvero BCU Blood Culture Application Receives Approval from Singapore Health Sciences Authority

Second market authorization for Unyvero Cartridges this year in Singapore
04/03/2018 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB

Markus Wolperdinger takes over the management of Fraunhofer IGB

Dr. Markus Wolperdinger has taken over the management of the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB as of March 1, 2018. Wolperdinger, who has a doctoral degree in chemistry and many years of industry experience in the field of industrial biotechnology and plant construction, is already very familiar with the Institu...
03/06/2018

Curetis subsidiary Ares Genetics wins incubator stay in Silicon Valley

Curetis N.V., a developer of next-level molecular diagnostic solutions, today announced that its wholly-owned subsidiary Ares Genetics GmbH (Vienna, Austria) has been selected as a winner of the “GoSiliconValley” competition of the Austrian Economic Chambers (WKO).
03/02/2018

One for all: super-resolution microscopy with one universal nanobody

To make cellular structures easily accessible for super-resolution microscopy, scientists at the Max Planck Institute for Terrestrial Microbiology in Marburg, the Natural and Medical Sciences Institute (NMI) in Reutlingen and the Eberhard Karls University of Tübingen have developed a new strategy for dense, unobtrusive labeling of proteins. In a st...
02/16/2018 | Eberhard Karls Universität Tübingen

New process allows tailor-made malaria research

Model of infection from Tübingen successfully tested in Africa: volunteers are being infected with malaria parasites in a controlled manner - New findings on naturally acquired immunity and resistance to malaria
02/13/2018 | CureVac AG

CureVac to Pursue Innovative mRNA Vaccines Against Flu and Malaria

Extends ongoing collaboration with Bill & Melinda Gates Foundation with award of two new grants
02/07/2018 | Eberhard Karls Universität Tübingen

Alzheimer’s research on mice – intracellular calcium store malfunction leads to brain hyperactivity

Physiologists at the University of Tübingen discover the mechanism leading to increased release of neurotransmitters – and potential new approaches to treatment
02/05/2018 | Curetis GmbH

Curetis Group: Ares Genetics Receives Funding Commitment For EUR 1.6 Mio. Project

Curetis N.V., a developer of next-level molecular diagnostic solutions, today announced that Ares Genetics GmbH (Vienna, Austria), a wholly-owned subsidiary of Curetis, has received notice from the Austrian Research Promotion Agency (FFG) that it has been awarded a grant for a EUR 1.6 million research project.
01/30/2018 | Eberhard Karls Universität Tübingen

What Magnetic Fields Do in the Brain – And How to Observe It

Tübingen Neuroscientists develop method to better understand transcranial magnetic stimulation (TMS)
01/19/2018 | Eberhard Karls Universität Tübingen

Promising malaria medication tested

New combination of drugs proves effective and well-tolerated – Further studies planned
01/19/2018 | Exyte

M+W Products celebrates ground-breaking ceremony for its new head offices

The new company head offices of M+W Products GmbH are being built in Renningen. On January 19, the long-established company is celebrating a groundbreaking ceremony to mark the start of construction work at the new Raite industrial estate. In addition to the invited guests on site, live transmission to the existing company building will ensure that...
01/10/2018 | Eberhard Karls Universität Tübingen

Immune response to bacteria: Distinguishing helpers from harmers

University of Tübingen microbiologists discover the mechanism staphylococci use to lull our immune systems.
01/10/2018 | CureVac AG

CureVac Highlights Key 2018 Corporate Milestones and Outlook

CureVac AG, a clinical-stage biopharmaceutical company pioneering mRNA-based drugs, today outlined key 2018 milestones in conjunction with its presentation at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco. The Company highlighted its clinical development milestones and strategy for the year, including plans to initiate clinical...
01/10/2018 | Curetis GmbH

Curetis and MGI Advance Strategic Partnership in NGS-Based Molecular Microbiology

Curetis N.V. (the "Company" and, together with Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic solutions, today announced that the Company is advancing its strategic alliance in NGS-based infectious disease testing.
01/08/2018 | Curetis GmbH

Curetis Expects Near-Term FDA Decision on De Novo Request

Curetis N.V. (the "Company" and, together with Curetis USA Inc. and Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic solutions, today provided a status update on the FDA De Novo filing for the Company’s Unyvero System and LRT Cartridge for the diagnosis of lower respiratory tract infections.